Related Experiment Video
Updated: May 8, 2026

13:36
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
10.5K
Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine
1Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
Lancet (London, England)
|December 26, 2021
Abstract
No abstract available in PubMed .

